Efficient Gene Transfer with Adeno-associated Virus-based Plasmids Complexed to Cationic Liposomes for Gene Therapy of Human Prostate Cancer

Cancer Research

Volumn 55, Issue 11, 1995, Pages 2366-2372

  Vieweg, Johannes ^a   Boczkowski, David ^a   Roberson, Kathryn M ^a   Edwards, Darryl W ^a   Philip, Mohan ^b   Philip, Ramila ^b   Rudoll, Tracy ^a   Smith, Clay ^a   Robertson, Cary ^a   Gilboa, Eli ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Applied Immune Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; INTERLEUKIN 2; LIPOSOME;

ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DNA BINDING; GENE INDUCTION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SECRETION; RAT;

ANIMAL; CATIONS; DEPENDOVIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMAN; INTERLEUKIN-2; LIPOSOMES; MALE; PLASMIDS; PROSTATIC NEOPLASMS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0029057646     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Carter, H. B., and Coffey, D. S. The prostate: an increasing medical problem. Prostate, 16: 39–48, 1990.
2. Choe, B. K., Frost, P., Morrison, M. K., and Rose, N. R. Natural killer cell activity of prostatic cancer patients. Cancer Invest., 5: 285–291, 1987.
3. Donovan, J. F., Lubaroff, D. M., and Williams, R. D. Immunotherapy of prostate cancer. Probl. Urol., 4: 489–505, 1990.
4. Ablin, R. J. Adjuvant immunotherapy for prostatic cancer. In: R. J. Ablin (ed.), Prostatic Cancer, pp. 251–283. New York: Marcel Dekker, Inc., 1981.
5. Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M., and Eisenbach, L. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res., 52: 3679–3686, 1992.
6. Porgador, A., Bannerji, R., Watanabe, Y., Feldman, M., Gilboa, E., and Eisenbach, L. Anti-metastatic vaccination of tumor-bearing mice with two types of γ-interferon gene inserted tumor cells. J. Immunol., 150: 1458–1463, 1993.
7. Porgador, A., Gansbacher, B., Bannerji, R., Tzehoval, E., Gilboa, E., Feldman, M., and Eisenbach, L. Anti-metastatic vaccination of tumor bearing mice with IL-2 gene inserted tumor cells. Int. J. Cancer, 53: 471-477, 1993.
8. Connor, J., Bannerji, R., Saito, S., Heston, W. Fair, W., and Gilboa, E. Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells. J. Exp. Med., 177: 1127–1134, 1993.
9. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539–3543, 1993.
10. Vieweg, J., Rosenthal, F., Bannerji, R., Heston, W., Fair, W., Gansbacher, B., and Gilboa, E. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res., 54: 1760–1765, 1994.
11. Saito, S., Bannerji, R., Gansbacher, B., Rosenthal, F. M., Romanenko, P., Heston, W. D. W., Fair, W. R., and Gilboa, E. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res., 54: 3516–3520, 1994.
12. Isaacs, J. T. Development and characteristics of the available animal model systems for the study of prostatic cancer. Current concepts and approaches to the study of prostate cancer. In: D. S. Coffey, W. A. Gardner, W. Bruchovsky, M. I. Resnick, and J. P. Karr (eds.), Current Concepts and Approaches to the Study of Prostate Cancer, pp. 513–576. New York: Alan R. Liss, 1987.
13. Peehl, D. M. Culture of human prostatic epithelial cells. In: R. I. Freshney (ed.), Culture of Epithelial Cells, pp, 159–180. New York: Wiley-Liss, 1992.
14. Jaffee, E., Dranoff, G., Cohen, L. K., Hauda, K. M., Clift, S., Marshall, F. F., Mulligan, R. C., and Pardoll, D. M. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res., 53: 2221–2226, 1993.
15. Sanda, M. G., Ayyagari, S. R., Jaffee, E. M., Epstein, J. I., Clift, S. L., Cohen, L. K., Dranoff, G., Pardoll, D. M., Mulligan, R. C., and Simons, J. W. Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151: 622–628, 1994.
16. Miller, D. G., Adam, M. A., and Miller, A. D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol., 10: 4239–4242, 1990.
17. Wang, C-Y., and Huang, L. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc. Natl. Acad. Sci. USA, 84: 7851–7855, 1987.
18. Feigner, P. L., Northrop, J. P., Ringold, G. M., and Danielsen, M. A highly efficient, lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA, 84: 7413–7417, 1987.
19. Rose, J. K., Buonocore, L., and Whitt, M. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques, 10: 520–522, 1991.
20. Philip, R., Brunette, E., Kilinski, L., Murugesh, D., McNally, M., Ucar, K., Rosenblatt, J., Okarma, T. B., and Lebkowski, J. S. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol., 14: 2411–2418, 1994.
21. Samulski, R. J., Chang, L-S., and Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol., 63: 3822–3828, 1989.
22. Price, J., Turner, D., and Cepko, C. Lineage analysis in the invertebrate nervous system by retrovirus mediated gene transfer. Proc. Natl. Acad. Sci. USA, 84: 156–160, 1987.
23. Smith, C., Muench, M. O., Knizewski, M., Gilboa, E., and Moore, M. A. S. Development of a lacz marked WEHI-3B D+ murine leukemic cell line as an in vitro model of acute non-lymphocytic leukemia. Leukemia (Baltimore), 7: 310–317, 1993.
24. Hantzopoulos, P. A., Sullenger, B. A., Ungers, G., and Gilboa, E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA, 86: 3519–3523, 1989.
25. Southern, P. J., and Berg, P. Transformation of mammalian cells to antibiotic resistance with bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet., 1: 327–332, 1982.
26. Feigner, J., Bennett, F., and Feigner, P. Cationic lipid-mediated elivery of polynucleotides. Methods (Orlando), 5: 67–75, 1993.
27. Beaton, A., Palumbo, P., and Berns, K. I. Expression from the adeno-associated virus p5 and pl9 promoters is negatively regulated in trans by the rep protein. J. Virol., 63: 4450–4454, 1989.
28. Tratschin, J-D., Tal, J., and Carter, B. J. Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol. Cell. Biol., 6: 2884–2894, 1986.